| Stage | PRVA | % of rev | USPH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $633M | 100.00% | $214M | 100.00% | PRVA ×2.96 |
| Gross profit | $563M | 89.04% | $87M | 40.43% | PRVA +48.6pp |
| Operating income | $12M | 1.86% | $22M | 10.25% | USPH +8.4pp |
| Pre-tax income | $17M | 2.65% | $19M | 8.90% | USPH +6.3pp |
| Net income | $10M | 1.54% | $15M | 6.96% | USPH +5.4pp |
| Stage | PRVA | USPH | Gap · A − B |
|---|---|---|---|
| Revenue | $633M100.00% | $214M100.00% | PRVA ×2.96 |
| Gross profit | 89.04%$563M | 40.43%$87M | PRVA +48.6pp |
| Operating income | 1.86%$12M | 10.25%$22M | USPH +8.4pp |
| Pre-tax income | 2.65%$17M | 8.90%$19M | USPH +6.3pp |
| Net income |
| 1.54%$10M |
| 6.96%$15M |
| USPH +5.4pp |
No shared counterparties.